| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $60K | — |
| R&D Expense | $285K | -33.2% |
| SG&A Expense | $5.7M | +25.8% |
| Operating Income | -$14.0M | -182.4% |
| Interest Expense | $248K | +5.6% |
| Pre-tax Income | -$16.0M | -154.7% |
| Income Tax | $0 | — |
| Net Income | -$16.0M | -150.1% |
| EPS (Basic) | -$0.12 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $453K | -0.9% |
| Current Assets | $637K | -10.7% |
| Total Assets | $5.3M | -52.9% |
| Current Liabilities | $2.6M | +72.5% |
| Total Liabilities | $7.7M | -21.4% |
| Stockholders' Equity | -$2.3M | -249.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.5M | +22.7% |
| Capital Expenditures | $40K | -58.4% |
| Investing Cash Flow | -$50K | -606.0% |
| Financing Cash Flow | $2.5M | -19.6% |
| Free Cash Flow | -$2.5M | +23.7% |
| -100.0% |
| EPS (Diluted) | -$0.12 | -100.0% |